Found: 43
Select item for more details and to access through your institution.
Recombinant human erythropoietin therapy for anemic cancer patients on combination chemotherapy.
- Published in:
- 1993
- By:
- Publication type:
- journal article
Are thrombosis, progression, and survival in ET predictable?
- Published in:
- 2024
- By:
- Publication type:
- Letter
Treatment of polycythemia vera with recombinant interferon.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Design and rationale for the life after stopping tyrosine kinase inhibitors (LAST) study, a prospective, single-group longitudinal study in patients with chronic myeloid leukemia.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Spatial relationship of chromosomes 9 and 22 at metaphase in patients with chronic myelogenous leukemia (CML).
- Published in:
- International Journal of Cancer, 1988, v. 41, n. 6, p. 829, doi. 10.1002/ijc.2910410609
- By:
- Publication type:
- Article
Interferon-αb: A New Treatment for Polycythemia Vera.
- Published in:
- Annals of Internal Medicine, 1993, v. 119, n. 11, p. 1091, doi. 10.7326/0003-4819-119-11-199312010-00006
- By:
- Publication type:
- Article
Combination Chemotherapy of Advanced Diffuse Histiocytic Lymphoma with the Six-Drug CO-BLAM Regimen.
- Published in:
- Annals of Internal Medicine, 1982, v. 97, n. 2, p. 190, doi. 10.7326/0003-4819-97-2-190
- By:
- Publication type:
- Article
Splenectomy in Chronic Myeloid Leukemia.
- Published in:
- Annals of Internal Medicine, 1978, v. 89, n. 5, p. 684, doi. 10.7326/0003-4819-89-5-684
- By:
- Publication type:
- Article
A comparative study of dibromomannitol and busulfan in the treatment of chronic myeloid leukemia. A study of cancer and leukemia group B.
- Published in:
- 1987
- By:
- Publication type:
- journal article
HAC-Cytoxan (cyclophosphamide) chemotherapy for ovarian carcinoma. Alternating chemotherapy with intensification.
- Published in:
- 1985
- By:
- Publication type:
- journal article
Continuous infusion vincristine and bleomycin with high dose methotrexate for resistant non-Hodgkin's lymphoma.
- Published in:
- 1982
- By:
- Publication type:
- journal article
Comparison of oral melphalan, CCNU, and BCNU with and without vincristine and prednisone in the treatment of multiple myeloma. Cancer and Leukemia Group B experience.
- Published in:
- 1982
- By:
- Publication type:
- journal article
A new effective four-drug combination of CCNU (1-[2-chloroethyl]-3-cyclohexyl-1-nitrosourea) (NSC-79038), vinblastine, prednisone, and procarbazine for the treatment of advanced Hodgkin's disease.
- Published in:
- 1980
- By:
- Publication type:
- journal article
Clinical trial of VP 16--213 (NSC 141540) I.V. twice weekly in advanced neoplastic disease: a study by the Cancer and Leukemia Group B.
- Published in:
- 1980
- By:
- Publication type:
- journal article
Factors associated with prolonged survival in chronic myeloid leukemia.
- Published in:
- Cancer (0008543X), 1978, v. 42, n. 4, p. 1957, doi. 10.1002/1097-0142(197810)42:4<1957::AID-CNCR2820420439>3.0.CO;2-2
- By:
- Publication type:
- Article
JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms.
- Published in:
- Nature Genetics, 2009, v. 41, n. 4, p. 446, doi. 10.1038/ng.334
- By:
- Publication type:
- Article
High dose methotrexate with citrovorum factor in adult resistant lymphoma.
- Published in:
- Cancer (0008543X), 1977, v. 40, n. 6, p. 2823, doi. 10.1002/1097-0142(197712)40:6<2823::AID-CNCR2820400612>3.0.CO;2-2
- By:
- Publication type:
- Article
Importance of bone marrow biopsy in the clinical staging of hodgkin's disease.
- Published in:
- Cancer (0008543X), 1970, v. 26, n. 2, p. 313, doi. 10.1002/1097-0142(197008)26:2<313::AID-CNCR2820260211>3.0.CO;2-R
- By:
- Publication type:
- Article
Blood Group Studies of Jungle Indians of the Mato Grosso.
- Published in:
- Transfusion, 1962, v. 2, n. 2, p. 110, doi. 10.1111/j.1537-2995.1962.tb00204.x
- By:
- Publication type:
- Article
A randomized, double-blind, placebo-controlled phase 3 study to assess efficacy and safety of ropeginterferon alfa-2b in patients with early/lower-risk primary myelofibrosis.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 9, p. 3573, doi. 10.1007/s00277-024-05912-8
- By:
- Publication type:
- Article
Hodgkin disease survivors at increased risk for problems in psychosocial adaptation.
- Published in:
- Cancer (0008543X), 1992, v. 70, n. 8, p. 2214, doi. 10.1002/1097-0142(19921015)70:8<2214::AID-CNCR2820700833>3.0.CO;2-X
- By:
- Publication type:
- Article
Second primary malignancies in postpolycythemia vera and postessential thrombocythemia myelofibrosis: A study on 2233 patients.
- Published in:
- Cancer Medicine, 2019, v. 8, n. 9, p. 4089, doi. 10.1002/cam4.2107
- By:
- Publication type:
- Article
Ruxolitinib for myelofibrosis--an update of its clinical effects.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Uncommon or Delayed Adverse Events Associated With Imatinib Treatment for Chronic Myeloid Leukemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2010, v. 10, n. 5, p. 331, doi. 10.3816/CLML.2010.n.065
- By:
- Publication type:
- Article
Long‐term effects of the treatment of polycythemia vera with recombinant interferon‐α.
- Published in:
- Cancer (0008543X), 2006, v. 107, n. 3, p. 451
- By:
- Publication type:
- Article
Guidelines for protocol studies in chronic lymphocytic leukemia.
- Published in:
- American Journal of Hematology, 1978, v. 4, n. 4, p. 343, doi. 10.1002/ajh.2830040406
- By:
- Publication type:
- Article
Response to pegylated interferon in a COVID‐19–positive elderly woman with primary myelofibrosis treated with ruxolitinib.
- Published in:
- Clinical Case Reports, 2021, v. 9, n. 4, p. 2228, doi. 10.1002/ccr3.3997
- By:
- Publication type:
- Article
Allogeneic Transplantation for Patients With Advanced Myelofibrosis: Splenomegaly and High Serum LDH are Adverse Risk Factors for Successful Engraftment.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Examination of platelet function in whole blood under dynamic flow conditions with the cone and plate(let) analyzer: effect of erythrocytosis and thrombocytosis.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Fedratinib in patients with myelofibrosis previously treated with ruxolitinib: An updated analysis of the JAKARTA2 study using stringent criteria for ruxolitinib failure.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 6, p. 594, doi. 10.1002/ajh.25777
- By:
- Publication type:
- Article
Impact of bone marrow fibrosis grade in post‐polycythemia vera and post‐essential thrombocythemia myelofibrosis: A study of the MYSEC group.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 1, p. E1, doi. 10.1002/ajh.25644
- By:
- Publication type:
- Article
Long-term treatment with ruxolitinib for patients with myelofibrosis: 5-year update from the randomized, double-blind, placebo-controlled, phase 3 COMFORT-I trial.
- Published in:
- Journal of Hematology & Oncology, 2017, v. 10, p. 1, doi. 10.1186/s13045-017-0417-z
- By:
- Publication type:
- Article
The effect of initial molecular profile on response to recombinant interferon-α (rIFNα) treatment in early myelofibrosis.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Studies of Serum Protein Abnormalities in Kala Azar.∗.
- Published in:
- Proceedings of the Society for Experimental Biology & Medicine, 1961, v. 106, n. 2, p. 365, doi. 10.3181/00379727-106-26340
- By:
- Publication type:
- Article
The clinical benefit of ruxolitinib across patient subgroups: analysis of a placebo-controlled, Phase III study in patients with myelofibrosis.
- Published in:
- British Journal of Haematology, 2013, v. 161, n. 4, p. 508, doi. 10.1111/bjh.12274
- By:
- Publication type:
- Article
Jumping translocations of the long arms of chromosome 1 in myeloid malignancies is associated with a high risk of transformation to acute myeloid leukaemia.
- Published in:
- 2010
- By:
- Publication type:
- Letter
Ex vivoevaluation of erythrocytosis-enhanced platelet thrombus formation using the cone and plate(let) analyzer: effect of platelet antagonists.
- Published in:
- British Journal of Haematology, 2004, v. 127, n. 2, p. 195, doi. 10.1111/j.1365-2141.2004.05190.x
- By:
- Publication type:
- Article
Evidence for a New Allele in the Kidd Blood Group System in Indians of Northern Mato Grosso, Brazil.
- Published in:
- Nature, 1960, v. 186, n. 4723, p. 481, doi. 10.1038/186481a0
- By:
- Publication type:
- Article
Predictive Value of In Vitro Mutation Data to Guide Second-Generation Tyrosine Kinase Inhibitor Selection: Ready for Prime Time?
- Published in:
- Oncologist, 2011, v. 16, n. 5, p. 554, doi. 10.1634/theoncologist.2010-0297
- By:
- Publication type:
- Article
Characterization of Chromosome 11 with a Complex Inversion and Deletion in an AML [M2] Using Fluorescence in situ Hybridization.
- Published in:
- Acta Haematologica, 1995, v. 94, n. 3, p. 152, doi. 10.1159/000204000
- By:
- Publication type:
- Article
Incidence of blast phase in myelofibrosis according to anemia severity.
- Published in:
- EJHaem, 2023, v. 4, n. 3, p. 679, doi. 10.1002/jha2.745
- By:
- Publication type:
- Article
Patient-Reported Functional Outcomes in Patients With Chronic Myeloid Leukemia After Stopping Tyrosine Kinase Inhibitors.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Cost-effectiveness of Tyrosine Kinase Inhibitor Treatment Strategies for Chronic Myeloid Leukemia in Chronic Phase After Generic Entry of Imatinib in the United States.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2016, v. 108, n. 7, p. 1, doi. 10.1093/jnci/djw003
- By:
- Publication type:
- Article